Longeveron Inc. (LGVN) - Latest Market Data

Price & Market Data

Price: $0.84

Daily Change: +$0.119 / 14.15%

Daily Range: $0.709 - $0.85

Market Cap: $25,916,642

Daily Volume: 377,667

Performance Metrics

1 Week: 5.49%

1 Month: -28.47%

3 Months: 29.02%

6 Months: 20.42%

1 Year: -45.68%

YTD: 42.73%

About Longeveron Inc. (LGVN)

Get the full picture of Longeveron Inc. (LGVN). Price: 0.84, daily change: +$0.119 / 14.15%. Market cap: 25,916,642. All performance metrics from 1-week to 1-year are here.

Company Details

Employees: 38

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Selected stocks

EZGO Technologies Ltd. (EZGO)

Diginex Limited (DGNX)

Virgin Galactic Holdings, Inc. (SPCE)

indie Semiconductor, Inc. (INDI)